Pharmaceuticals

New study finds omicron no less severe than earlier variants, and not just more transmissible

New study finds omicron no less severe than earlier variants, and not just more transmissible

A new study conducted by researchers at Harvard Medical School among others has found that the omicron variant of the coronavirus that causes COVID-19 is just as severe as earlier variants, and not more transmissible but no less severe, as previously thought. The study was based on the records of 130,000 COVID patients in Massachusetts …

New study finds omicron no less severe than earlier variants, and not just more transmissible Read More »

WSJ News Exclusive | Bausch + Lomb Prices IPO at $18 a Share, Below Expectations

WSJ News Exclusive | Bausch + Lomb Prices IPO at $18 a Share, Below Expectations

Bausch + Lomb Corp. priced its IPO at $18 a share Thursday, falling short of expectations as it became the first big company in months to try going public into a turbulent stock market. Bausch Health BHC -7.40% Cos., the parent company, raised $630 million in the offering. It had been aiming to raise as …

WSJ News Exclusive | Bausch + Lomb Prices IPO at $18 a Share, Below Expectations Read More »